Phase 3 study investigating the efficacy and safety of roxadustat for treatment of anemia in patients with lower risk Myelodysplastic Syndrome (MDS) and low Red Blood Cell (RBC) transfusion burden.

Staff Spotlight: Hadley

What is your name? Hadley What is your role at OSC? NP, Nurse Practitioner, I have been with the practice over 5 years What is your Educational Background? I graduated from Clemson University with a bachelors in nursing, BSN. I worked in nursing a...